These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 12750439

  • 1. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
    Summers MA, O'Dorisio MS, Cox MO, Lara-Marquez M, Goetzl EJ.
    J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
    [Abstract] [Full Text] [Related]

  • 2. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D, Ribeiro JA, Sebastião AM.
    Brain Res; 2005 Jul 05; 1049(1):52-60. PubMed ID: 15935995
    [Abstract] [Full Text] [Related]

  • 3. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents.
    Fizanne L, Sigaudo-Roussel D, Saumet JL, Fromy B.
    J Physiol; 2004 Jan 15; 554(Pt 2):519-28. PubMed ID: 14578481
    [Abstract] [Full Text] [Related]

  • 4. Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries.
    Grant S, Lutz EM, McPhaden AR, Wadsworth RM.
    J Cereb Blood Flow Metab; 2006 Jan 15; 26(1):58-67. PubMed ID: 15959462
    [Abstract] [Full Text] [Related]

  • 5. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S, Pineau N, Becq-Giraudon L, Gressens P, Muller JM, Janet T.
    J Neuroimmunol; 2005 Jan 15; 158(1-2):94-105. PubMed ID: 15589042
    [Abstract] [Full Text] [Related]

  • 6. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
    Kojima M, Ito T, Oono T, Hisano T, Igarashi H, Arita Y, Kawabe K, Coy DH, Jensen RT, Nawata H.
    Pancreas; 2005 Jan 15; 30(1):62-70. PubMed ID: 15632701
    [Abstract] [Full Text] [Related]

  • 7. Hexanoylation of a VPAC2 receptor-preferring ligand markedly increased its selectivity and potency.
    Langer I, Gregoire F, Nachtergael I, De Neef P, Vertongen P, Robberecht P.
    Peptides; 2004 Feb 15; 25(2):275-8. PubMed ID: 15063009
    [Abstract] [Full Text] [Related]

  • 8. Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation.
    St Hilaire RC, Murthy SN, Kadowitz PJ, Jeter JR.
    Peptides; 2010 Aug 15; 31(8):1517-22. PubMed ID: 20452385
    [Abstract] [Full Text] [Related]

  • 9. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS, Wood CL, Wenger GD, Vassalo LM.
    J Immunol; 1985 Jun 15; 134(6):4078-86. PubMed ID: 2985703
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy.
    Dvoráková MC, Pfeil U, Kuncová J, Svíglerová J, Galvis G, Krasteva G, König P, Grau V, Slavíková J, Kummer W.
    Cell Tissue Res; 2006 Mar 15; 323(3):383-93. PubMed ID: 16344947
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart.
    Sawmiller DR, Ashtari M, Urueta H, Leschinsky M, Henning RJ.
    Neuropeptides; 2006 Oct 15; 40(5):349-55. PubMed ID: 17030371
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.
    Juarranz Y, Gutiérrez-Cañas I, Santiago B, Carrión M, Pablos JL, Gomariz RP.
    Arthritis Rheum; 2008 Apr 15; 58(4):1086-95. PubMed ID: 18383383
    [Abstract] [Full Text] [Related]

  • 13. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S, Röcken C, Mawrin C, Weise W, Höllt V, Schulz S.
    Clin Cancer Res; 2004 Dec 15; 10(24):8235-42. PubMed ID: 15623599
    [Abstract] [Full Text] [Related]

  • 14. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO, Collado B, Bodega G, Cortés J, Ruíz-Villaespesa A, Carmena MJ, Prieto JC.
    Gynecol Endocrinol; 2005 Jun 15; 20(6):327-33. PubMed ID: 16019382
    [Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal peptide (VIP) stimulates cortisol secretion from the H295 human adrenocortical tumour cell line via VPAC1 receptors.
    Nicol MR, Cobb VJ, Williams BC, Morley SD, Walker SW, Mason JI.
    J Mol Endocrinol; 2004 Jun 15; 32(3):869-77. PubMed ID: 15171718
    [Abstract] [Full Text] [Related]

  • 16. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug 15; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I.
    Oncol Rep; 2005 Jun 15; 13(6):1217-21. PubMed ID: 15870945
    [Abstract] [Full Text] [Related]

  • 18. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR, Henning RJ, Cuevas J, Dehaven WI, Vesely DL.
    Neuropeptides; 2004 Oct 15; 38(5):289-97. PubMed ID: 15464194
    [Abstract] [Full Text] [Related]

  • 19. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M, Huang MC, Goetzl EJ.
    Cell Immunol; 2011 Oct 15; 267(2):124-32. PubMed ID: 21295288
    [Abstract] [Full Text] [Related]

  • 20. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
    Marie JC, Rouyer-Fessard C, Couvineau A, Nicole P, Devaud H, El Benna J, Laburthe M.
    Mol Pharmacol; 2003 Dec 15; 64(6):1565-74. PubMed ID: 14645688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.